SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-17-000035
Filing Date
2017-11-09
Accepted
2017-11-08 20:27:48
Documents
89
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20170930x10q.htm 10-Q 2680917
2 EX-10.1 amph-20170930ex10170c817.htm EX-10.1 955321
3 EX-31.1 amph-20170930ex3119ecc32.htm EX-31.1 22865
4 EX-31.2 amph-20170930ex312064c22.htm EX-31.2 22991
5 EX-32.1 amph-20170930ex32118241b.htm EX-32.1 12353
6 EX-32.2 amph-20170930ex3224240ae.htm EX-32.2 12326
  Complete submission text file 0001297184-17-000035.txt   11966177

Data Files

Seq Description Document Type Size
7 EX-101.INS amph-20170930.xml EX-101.INS 2746374
8 EX-101.SCH amph-20170930.xsd EX-101.SCH 70940
9 EX-101.CAL amph-20170930_cal.xml EX-101.CAL 53691
10 EX-101.DEF amph-20170930_def.xml EX-101.DEF 238925
11 EX-101.LAB amph-20170930_lab.xml EX-101.LAB 496915
12 EX-101.PRE amph-20170930_pre.xml EX-101.PRE 442102
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 171188009
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences